Eileen P. Scanlan, A. May
May 1, 1963
Citations
0
Influential Citations
2
Citations
Quality indicators
Journal
British Journal of Psychiatry
Abstract
The purpose of this trial was to evaluate the drug Taractan in the treatment of chronic schizophrenia. Taractan (chlorprothixene) is chemically α-2-chloro-9-(w-dimethylamino propylidene)-thioxanthene. It is claimed to have neuroleptic and tranquillizing properties as well as thymoleptic activity. It is also claimed to be relatively free from side-effects. This property facilitated its use in a double-blind study.